(1)Lingfeng Yu, Hao Zhu, Zhen Wang, Yan Zhu, Gentao Fan, Yichun Wang，Xi Chen, Guangxin Zhou. Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling. Mol Cancer. 2022 Aug 19;21(1):167. doi: 10.1186/s12943-022-01624-7通讯作者。 IF=41.44
(2)Wang Y, Liu Y, Wang L, Chen Z, Ye Q, Chen K, Zhao C, Yang M, Xia W, Zhang M, Qiao J, Zhou G, Wu J. Combretastatin A4-Based Albumin Nanoparticles Remodeling the Tumor Immune Microenvironment to Enhance T Cell Immunotherapy in Colon Cancer. ACS Nano. 2025 Jun 24. doi: 10.1021/acsnano.5c03638. 通讯作者。IF=16.1
(3)Li B, Xie L, Liang J, Jiang Y, Wang K, Liu Y, Lin N, Huang X, Zhao K, Fan G, Liu M, Yan X, Qu H, Li H, Yang J, Zhou G, Ye Z. Anti-PD-1 antibody plus anlotinib vs. anlotinib alone in patients with refractory chondrosarcoma: A multicenter, non-randomized phase 2 FLAIL-C trial. Med. 2025 Aug 26:100809. pii: S2666-6340(25)00236-3. doi: 10.1016/j.medj.2025.100809. 通讯作者。IF=11.8
(4)Yu L, Fan G, Wang Q, Zhu Y, Zhu H, Chang J, Wang Z, Zhan S, Hua X, She D, Huang J, Wang Y, Zhao J, Zhang CY, Chen X, Zhou G. In vivo self-assembly and delivery of VEGFR2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy. Cell Death Dis. 2023 Sep 22;14(9):626. doi: 10.1038/s41419-023-06159-3. 通讯作者。 IF=9.0
(5)Wang Z, Fan G, Zhu H, Yu L, She D, Wei Y, Huang J, Li T, Zhan S, Zhou S, Zhu Y, Wang Y, Chen X, Zhao J, Zhou G. PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma. Front Oncol. 2022 Oct 5;12:980390. doi: 10.3389/fonc.2022.980390.通讯作者。 IF= 5.738
(6) Huang J, Lu J, Liu Z, Jin J, Xie C, Zheng Y, Wang Z, Yu L, Zhu Y, Fan G, Sun G, Xu Z, Zhou G. Covalent immobilization of VEGF on allogeneic bone through polydopamine coating to improve bone regeneration. Front Bioeng Biotechnol. 2022 Oct 12;10:1003677. doi: 10.3389/fbioe.2022.1003677. 通讯作者。 IF= 6.064
(7) Huang J, Han Q, Cai M, Zhu J, Li L, Yu L, Wang Z, Fan G, Zhu Y, Lu J, Zhou G. Effect of Angiogenesis in
Bone Tissue Engineering. Ann Biomed Eng. 2022 Aug;50(8):898-913. doi: 10.1007/s10439-022-02970-9. Epub 2022 May 7.通讯作者。IF=4.22,
(8)Fan G, Zhu Y, Zhu H, Yu L, Wang Z, Zhai C, Zhou G, Zhao J, Wang Y. Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma. Biomed Res Int. 2023 Feb 7;2023:1150768. doi: 10.1155/2023/1150768. eCollection 2023. 共同通讯作者IF=2.583
(9) Meng Cai, Gentao Fan, Guangxin Zhou. Efficacy and safety of treating refractory bone and soft tissue sarcoma with anlotinib in different treatment patterns. Comput Math Methods Med. 2022 Aug 11;2022:3287961. doi: 10.1155/2022/3287961. 通讯作者。IF=2.809
(10) Zhu K, Liu L, Zhang J, Wang Y, Liang H, Fan G, Jiang Z, Zhang CY, Chen X, Zhou G. MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6. Protein Cell. 2016 Jun;7(6):434-44. doi: 10.1007/s13238-016-0277-2. Epub 2016 May 26.（通讯作者）IF=5.37
(11) Yicun Wang, Jinhui Wu, Hui Chen, Yang Yang, Chengwu Xiao, Xiaoming Yi, Changjie Shi , Ke Zhong, Haowei He, Yaoming Li , Zhenjie Wu, Guangxin Zhou, Qiu Rao, Xiaoxia Wang , Xiaodie Zhou, Gwen Lomberk, Bing Liu, Jianning Zhao, Jingping Ge, Wenquan Zhou, Xiaoyuan Chu, Cheng Chen, Xuhui Zhou, Linhui Wang, Kunliang Guan, Le Qu。Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells。Sci Adv. 2021 Jan 27;7(5):eabe3445. doi: 10.1126/sciadv.abe3445.
(12) Yan Zhu, Gentao Fan, Lili Cao, Hao Zhu, Sujia Wu, Jianning Zhao & GuangxinZhou。Survival outcomes of patients with brain metastasis of osteosarcoma can be improved by aggressive multi-disciplinary interventionsincluding chemotherapy。Br J Neurosurg. 2021 Jul 15:1-6. doi: 10.1080/02688697.2021.1950624.（通讯作者）IF=1.59
(13)Fan GT, Ling ZH, He ZW, Wu SJ, Zhou GX. Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma.Biochem Biophys Res Commun. 2021 May 21;554:214-221. doi: 10.1016/j.bbrc.2020.12.109. Epub 2021 Apr 1.（通讯作者）IF=3.02
(14)Jin Y, Zhang J, Zhu H, Fan G, Zhou G.Expression profiles of miRNAs in giant cell tumor of bone showed miR-187-5p and miR-1323 can regulate biological functions through inhibiting FRS2.Cancer Med. 2020 May;9(9):3163-3173. doi: 10.1002/cam4.2853. Epub 2020 Mar 10.（通讯作者）IF=2.45、
(15) Jin YH,Zhang J,Zhu H, Fan GT, Zhou GX.Functions of Exogenous RUNX2 in Giant Cell Tumor of Bone In Vitro.Orthop Surg. 2020 Apr;12(2):668-678. doi: 10.1111/os.12568. Epub 2020 Mar 10.（通讯作者）IF=1.14
(16) Fan G, He Z, Cao L, Shi X, Wu S, Zhou G. miR-139 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1. Front Biosci (Landmark Ed). 2019 Jun 1;24(6):1167-1177. doi: 10.2741/4773.（通讯作者）IF=2.34
(17)Zhong Y, Zhu Y, Li Q, Wang F, Ge X, Zhou G, Miao L. Association between Mediterranean diet adherence and colorectal cancer: a dose-response meta-analysis. Am J Clin Nutr. 2020 May 2. pii: nqaa083. （共同通讯作者）IF=5.97
(18)Xiaozhou L, Xing Z, Xin S, Chengjun L, Lei Z, Guangxin Z, Sujia W. Efficacy Analysis of Separation Surgery Combined with SBRT for Spinal Metastases-A Long-Term Follow-Up Study Based on Patients with Spinal Metastatic Tumor in a Single-Center. Orthop Surg. 2020 Apr;12(2):404-420. doi: 10.1111/os.12594. Epub 2020 Feb 8.（共同通讯作者）IF=1.14
(19)Ling Z, Fan G, Yao D, Zhao J, Zhou Y, Feng J, Zhou G, Chen Y. MicroRNA-150 functions as a tumor suppressor and sensitizes osteosarcoma to doxorubicin-induced apoptosis by targeting RUNX2. Exp Ther Med. 2020 Jan;19(1):481-488. doi: 10.3892/etm.2019.8231. Epub 2019 Nov 22.（共同通讯作者）IF=1.42
(20)Liang H, Fu Z, Jiang X, Wang N, Wang F, Wang X, Zhang S, Wang Y, Yan X, Guan WX, Zhang CY, Zen K, Zhang Y, Chen X, Zhou G。miR-16 promotes the apoptosis of human cancer cells by targeting FEAT.BMC Cancer. 2015 Jun 2;15:448. doi: 10.1186/s12885-015-1458-8.（通讯作者）IF=3.32
(21)Guangxin Zhou, Meng Lu, Jijun Chen, Chengjun Li, Junfeng Zhang, Jiangning Chen,*, Xin Shi, Sujia Wu. Identification of circulating microRNAs in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma. Tumour Biol. 2015 Nov;36(11):8845-52. doi: 10.1007/s13277-015-3421-3. Epub 2015 Jun 12. 第一作者）IF=2.84
(22)Zhang YQ, Li Y, Liu H, Bai J, Bao NR, Zhang Y, He P, Zhao JN, Tao L, Xue F, Zhou GX, Fan GT。Mechanical and Biological Properties of a Biodegradable Mg-Zn-Ca Porous Alloy。Orthop Surg. 2018 May;10(2):160-168. doi: 10.1111/os.12378. Epub 2018 May 16. （共同通讯作者）IF=1.14
(23)Zhou Guangxin, Chen Xiaoyu， Wu Sujia, Shi Xin, Chen Jiangning, Zhang Junfeng. Preparation and antitumor activity of a polymer derivative of metrotrexate. Am J Med Sci. 2012 Oct;344(4):294-9. doi: 10.1097 (第一作者)IF=1.334
(24)Zhi, Feng; Zhou Guangxin; Wang, Suinuan; Shi, Yimin; Peng, Ya; Shao, Naiyuan; Guan, Wei; Qu, Hongtao; Zhang, Yi; Wang, Qiang; Yang, Changchun; Wang, Rong; Wu, Sujia; Xia, Xiwei; Yang, Yilin A microRNA expression signature predicts meningioma recurrence. Int J Cancer. 2013 Jan 1;132(1):128-36. doi: 10.1002/ijc.27658. Epub 2012 Jun 26.（共同第一作者）IF=6.198
(25)Guangxin Zhou, Xin Shi, Junfeng Zhang, Sujia wu, Jianning Zhao. MicroRNAs in osteosarcoma: from biological players to clinical contributors. J Int Med Res. 2013 Feb;41(1):1-12. doi: 10.1177/0300060513475959. Epub 2013 Jan 24. （第一作者）IF=1.095
(26)Feng Zhi, , Guangxin Zhou, Naiyuan Shao, Xiwei Xia, Yimin Shi, Qiang Wang, Yi Zhang, Rong Wang, Lian Xue, Suinuan Wang, Sujia Wu, Ya Peng, Yilin Yang. miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK. PLoS One. 2013 Aug 27;8(8):e72390. doi: 10.1371/journal.pone.0072390 （共同第一作者）IF=3.73